Form 10-K Filing Date 02.14.2024 Document Date 12.31.2023 Form Description Annual report which provides a comprehensive overview of the company for the past ...

10.31.2024, 10-Q. Quarterly report which provides a continuing view of a company's financial position. Quarterly Filings.

Amgen Inc. - 10K - Annual Report - February 14, 2024.

View the latest AMGN 10K form and other Securities and Exchange Commission (SEC) filings for Amgen (NASDAQ:AMGN) at MarketBeat.

The main purpose of Amgen 10K is to help investors understand the financial performance of Amgen so that they can make informed decisions. 2024-02-14, AMGEN INC ...

Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular ...

Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Amgen Inc (AMGN) using our online tools.

14 февр. 2024 г. · AMGEN INC reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-02-14 16:23:32 EST.

A biotechnology pioneer, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world ...

17 апр. 2024 г. · Amgen Inc (AMGN) SEC Filing DEF 14A Proxy Statement Report for the fiscal year ending Friday, May 31, 2024.